ADARx Pharmaceuticals, Inc. (ADRX) stock
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$12.82−1.00 (-7.24%)
Close on Nov 18, 2026Market cap $1.38BP/E –Yield –
ADARx Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for ADARx Pharmaceuticals
ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?